Page last updated: 2024-09-02

npc 12626 and u 69593

npc 12626 has been researched along with u 69593 in 2 studies

Compound Research Comparison

Studies
(npc 12626)
Trials
(npc 12626)
Recent Studies (post-2010)
(npc 12626)
Studies
(u 69593)
Trials
(u 69593)
Recent Studies (post-2010) (u 69593)
5500524075

Protein Interaction Comparison

ProteinTaxonomynpc 12626 (IC50)u 69593 (IC50)
Kappa-type opioid receptorRattus norvegicus (Norway rat)0.0006
Mu-type opioid receptorHomo sapiens (human)0.194
Delta-type opioid receptorHomo sapiens (human)3.6437
Kappa-type opioid receptorCavia porcellus (domestic guinea pig)0.0021
Kappa-type opioid receptorHomo sapiens (human)0.058
Mu-type opioid receptorCavia porcellus (domestic guinea pig)0.588

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kavaliers, M; Saucier, DM1
Choleris, E; Kavaliers, M; Saucier, DM1

Other Studies

2 other study(ies) available for npc 12626 and u 69593

ArticleYear
Antagonistic effects of the selective, competitive N-methyl-D-aspartate (NMDA) receptor antagonist, NPC 12626, on kappa opiate-induced analgesia in male deer mice.
    Brain research, 1994, Feb-21, Volume: 637, Issue:1-2

    Topics: Amino Acids; Analgesics; Animals; Benzeneacetamides; Dizocilpine Maleate; Dose-Response Relationship, Drug; Male; Morphine; Naloxone; Naltrexone; Nociceptors; Pain Measurement; Peromyscus; Pyrrolidines; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid, kappa

1994
The NMDA receptor antagonist, NPC 12626, reduces the pronociceptive effects of orphanin FQ and kappa opiate antinociception in the land snail, Cepaea nemoralis.
    Peptides, 1997, Volume: 18, Issue:7

    Topics: Amino Acids; Animals; Benzeneacetamides; Biological Evolution; Nociceptin; Nociceptors; Opioid Peptides; Pyrrolidines; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid, kappa; Snails

1997